BOENNING & SCATTERGOOD, INC. – Eli Lilly and Company Transaction History
BOENNING & SCATTERGOOD, INC. portfolio value:
$3.40M
portfolio value
BOENNING & SCATTERGOOD, INC. quarter portfolio value change:
-0.27%
quarter
Eli Lilly and Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +9.52% | 916 shares | 288K | $323.35 | 10.54K |
| Q2 2022 | share | 0.00% | 0 shares | 364K | $324.23 | 9.62K | |
| Q1 2022 | share | Increase | +0.28% | 27 shares | 105K | $286.37 | 9.62K |
| Q4 2021 | share | Increase | +2.40% | 225 shares | 486K | $277.25 | 9.59K |
| Q3 2021 | share | Decrease | -0.79% | -75 shares | -3K | $230.3 | 9.37K |
| Q2 2021 | share | Increase | +1.34% | 125 shares | 426K | $228.04 | 9.44K |
| Q1 2021 | share | Increase | +6.88% | 600 shares | 269K | $184.81 | 9.32K |
| Q4 2020 | share | Increase | +0.08% | 7 shares | 183K | $166.32 | 8.72K |
| Q3 2020 | share | Increase | +3.00% | 254 shares | -99K | $145.05 | 8.71K |
| Q2 2020 | share | Increase | +57.97% | 3.10K shares | 646K | $160.1 | 8.46K |
| Q1 2020 | share | Decrease | -0.28% | -15 shares | 37K | $134.64 | 5.35K |
| Q4 2019 | share | 0.00% | 0 shares | 105K | $126.91 | 5.37K | |
| Q3 2019 | share | Decrease | -1.38% | -75 shares | -2K | $107.36 | 5.37K |
| Q2 2019 | share | Increase | +8.46% | 425 shares | -49K | $105.74 | 5.44K |
| Q1 2019 | share | Decrease | -32.34% | -2.4K shares | -207K | $123.17 | 5.02K |
| Q4 2018 | share | Decrease | -27.68% | -2.84K shares | -242K | $109.26 | 7.42K |
| Q3 2018 | share | Increase | +4.06% | 400 shares | 260K | $100.8 | 10.26K |
| Q2 2018 | share | Increase | 0.00% | 9.86K shares | 841K | $79.72 | 9.86K |